Epinephrine formulations
AssigneeAzopharma, Inc.
InventorsJon Bruss, John McCarty, Blair West
Life of this patent
Estimating the term…
Abstract
The present invention generally concerns an epinephrine formulation that has enhanced stability. In particular embodiments, the formulation is an injectable formulation. In specific aspects, the formulation comprises epinephrine, EDTA, and one or more of an antioxidant such as cysteine, citric acid, acetylcysteine, or thioglycerol. The formulations are suitable for any medical condition that is in need of epinephrine, although in specific embodiments the medical condition is anaphylaxis, asthma, or cardiac arrest.
Claims22
An injectable pharmaceutical composition comprising epinephrine, EDTA, and at least one antioxidant, wherein the antioxidant is selected from the group consisting of cysteine, citric acid, thioglycerol, acetylcysteine, and a combination thereof.
A kit, comprising:
- a pharmaceutical composition comprising epinephrine, EDTA, and at least one antioxidant, wherein the antioxidant is selected from the group consisting of cysteine, citric acid, thioglycerol, acetylcysteine, and a combination thereof;
- and
- an injection apparatus.
A method of improving at least one symptom of an epinephrine-requiring medical condition in an individual in need thereof, comprising injecting into the individual a formulation comprising:
- epinephrine;
- EDTA;
- a pharmaceutically acceptable carrier;
- and
- at least one antioxidant, wherein the at least one antioxidant is selected from the group consisting of cysteine, citric acid, thioglycerol, acetylcysteine, and a combination thereof.
A method of treating anaphylaxis in an individual comprising injecting into the individual a formulation, said formulation comprising:
- epinephrine;
- EDTA;
- a pharmaceutically acceptable carrier;
- and
- at least one antioxidant, wherein the at least one antioxidant is selected from the group consisting of cysteine, citric acid, thioglycerol, acetylcysteine, and a combination thereof, wherein the formulation is injected by an auto-injector.
A method of treating a pediatric individual in need of treatment for anaphylaxis comprising injecting into the individual a formulation comprising:
- epinephrine;
- EDTA;
- and
- at least one antioxidant, wherein the at least one antioxidant is selected from the group consisting of cysteine, citric acid, thioglycerol, acetylcysteine, and a combination thereof.
Dependencies are inferred from the claim text.